Review of Chinese Botanical Drugs Targeting Mitochondrial Dysfunction in Osteoporosis

A 48.0 KB review document summarizes the role of mitochondrial dysfunction in osteoporosis and catalogs Chinese botanical drugs targeting it. Author Shiyu Li published the document on figshare under a CC-BY-4.0 license in May 2026. The review aims to establish a research paradigm linking botanical drugs, mitochondria, and bone health.

Use Cases

• Literature review on mitochondrial mechanisms in osteoporosis based on the described biological processes
• Identification of candidate natural compounds for drug discovery based on the listed metabolites like resveratrol
• Analysis of multi-target therapeutic strategies based on the 'multiple targets, multi-levels' concept of Chinese botanical drugs

Strengths

• Document is published under a permissive CC-BY-4.0 license
• The review systematically catalogs specific drug formulations like Zuogui Pill

Limitations

• The dataset is a 48.0 KB review document, not a primary data collection, limiting direct analysis
• Column-level documentation is absent; field semantics must be inferred after download
• Row count is unknown, which may limit suitability assessment

Provenance

Source

figshare

Collection Method

Authored review article

Freshness

Last updated 2026-05-14 05:46:52; freshness should be verified